Pfizer joins next-gen vaccines R&D consortium

Pfizer ($PFE) has joined the public/private Human Vaccines Project, which is engaged in the hunt for a new generation of vaccines that can tackle cancer, HIV, dengue and more. "Over the last decade, we've seen unprecedented technological advances in our understanding of the biology of diseases, and new tools in designing vaccines including therapeutic vaccines. Yet the translation from preclinical to clinical vaccine research has often been hampered by a lack of understanding of the desired human immune responses required to obtain optimal vaccine protection," said Kathrin Jansen, senior vice president and head of Vaccines Research & Development at Pfizer. Release